Evaluation of EXL01, a New Live Biotherapeutic Product to Prevent Recurrence of Clostridioides Difficile Infection in High-risk Patients
Clinical trial NCT06306014 · RECRUITING
Trial details
- NCT number
- NCT06306014
- Sponsor
- Hospices Civils de Lyon
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-05-07
- Primary completion
- 2028-01-07
- Enrollment
- 56
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.